Clinical Trial Results TV
May 7, 2009: Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy
Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy at the 2009 SCAI
Scientific Sessions in Las Vegas.

Research Grants
-Sanofi-Aventis, Schering-Plough, Eli Lilly, Daiichi-Sankyo, Bristol-Myers Squibb, CV
Therapeutics, Datascope, and the Medicines Company
Stock Ownership
-Inovise
Consultant
-Response Biomedical, Northpoint Domain, CV Therapeutics, The Medicines Company, Abiomed,
Datascope, Liposcience and Inovise Medical

[ Download video ]


Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 1 total votes.

These statistics are updated nightly. The last update ran on
11-22-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted